Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2019-01-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
关于会计估计变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about a change in accounting estimates related to depreciation policies following a major asset acquisition. It details the reasons for the change, the specific accounting estimate adjustments, the date of change, and the expected financial impact. It includes statements from the board, independent directors, and the supervisory board approving the change. The document is relatively short (2773 characters) and does not contain full financial statements or comprehensive financial data. It is not a full annual or interim report, nor is it an earnings release or audit report. It is a regulatory announcement about an accounting policy change, which fits best under Regulatory Filings (RNS) as it does not meet the criteria for a full financial report or other specific categories.
2019-01-11 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 中粮生物化学（安徽）股份有限公司 regarding a change in accounting policies. It details the reasons for the change, the effective date, and the opinions of the board, independent directors, and supervisory board. The document does not contain actual financial statements or detailed financial data but rather informs stakeholders about the policy change and its expected impact. The length is relatively short (2075 characters), and it serves as a formal announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for announcements that do not fit other specific report types.
2019-01-11 Chinese
关于开展2019年度期货套期保值业务的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by a company regarding its plan to conduct futures hedging business for the year 2019. It details the purpose, scope, risk analysis, risk control measures, accounting policies, and independent directors' opinions on the hedging activities. The document is a formal announcement of a business activity and related risk management, not a financial report, earnings release, or regulatory filing about financial results. It does not contain financial statements or quarterly/yearly results. It is also not a report publication announcement or certification. The content fits best under a general regulatory announcement category about business operations and risk management, which aligns with Regulatory Filings (RNS). The document length is 2706 characters, which is relatively short and consistent with an announcement rather than a full report.
2019-01-11 Chinese
独立董事关于公司开展2019年度期货套期保值业务涉及关联交易事项的事前确认函
Regulatory Filings Classification · 95% confidence The document is an independent director's confirmation letter regarding the company's 2019 futures hedging business involving related party transactions. It discusses the review and approval of the transaction, compliance with laws and regulations, internal controls, and fairness to shareholders. The document is short (844 characters) and does not contain financial statements or detailed financial data. It is a confirmation or attestation letter rather than a full report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications, attestations, and miscellaneous regulatory documents that do not fit other categories.
2019-01-11 Chinese
关于“三供一业”分离移交的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors of 中粮生物化学（安徽）股份有限公司 regarding the approval of a proposal related to the separation and transfer of "三供一业" (three supplies and one industry) to local governments or other entities. It includes details about the policy background, scope of the transfer, estimated costs, financial impact on the company, and internal decision-making procedures. The document is relatively short (2156 characters) and does not contain financial statements or detailed financial analysis. It is a formal announcement of a corporate action approved by the board, not a full financial report or earnings release. It also does not fit into categories like management changes, capital updates, or legal proceedings. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2019-01-11 Chinese
七届监事会2019年第一次临时会议决议公告
Regulatory Filings
2019-01-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.